Coronavirus (COVID-19) - update on services for patients and families
19 Mar 2020, 11:25 a.m.
In order to ensure that the NHS is prepared to manage the impact of the COVID-19 pandemic, all hospitals are taking very difficult decisions about how to prioritise patient care.
As of this week, following a directive from NHS England, we will be reducing all of our non-essential activity. This will mean that many procedures, admissions and appointments will be postponed. We would like to reassure you that postponement of any non-essential treatment will only be made after careful assessment by the clinical teams on a case-by-case basis. If you are affected by these changes you will be contacted directly so that individual arrangements can be made.
We hope that you will understand that it may not be possible for us to confirm exactly when your admission or appointment will go ahead at this stage.
Please be assured we are doing everything we can to make sure that you are kept safe.
We have not taken this decision lightly. In times when the NHS system is likely to be placed under severe stress, we believe that this is the best way for us to be able to deliver urgent care to children from across London.
We know you might be worried about these temporary changes. We would like to reassure you that we are carrying out regular reviews to ensure that the safety of all our patients, families and colleagues are taken into consideration.
Further information for GOSH patients, young people and families is available on our regularly updated FAQ guidance.
Surgery in the womb for spina bifida has stopped paralysis in dozens of babies
Dozens of babies with spina bifida have been spared paralysis and other life-limiting conditions after undergoing surgery in the womb in a cutting-edge procedure made available on the NHS.
Get Active: Cancer Sports Day 2021
On 3 July 2021 the GOSH Oncology team's cancer sports day is back, reuniting UCL and GOSH patients past and present with the wide spectrum of GOSH staff involved in their care, including doctors, nurses, physios and dietitians.
Common inflammatory bowel disease treatment is linked to reduced COVID-19 antibody response
New evidence indicates the commonly-prescribed inflammatory bowel disease (IBD) drug infliximab blunts the immune system to COVID-19 infection, potentially increasing the risk of reinfection.
GOSH and Moorfields treat the UK’s youngest patient with sight-saving gene therapy
Three year old Leo and his family appear in BBC 2's DNA Family Secrets to share their journey for answers into his condition and his successful treatment with Voretigene Neparvovec